Give Kids a Chance Act of 2025

This bill does two main things related to children's health. First, it makes it easier to research new cancer treatments for kids by allowing clinical trials that combine new drugs with ones already approved for treating cancer in children or adults. Second, it brings back a program, which expired in December 2024, that gives special rewards called priority review vouchers to companies that develop treatments for rare diseases in children, extending it through September 30, 2029. The bill also requires the FDA to provide guidance on how these changes will work and requires reports from both the FDA and the Government Accountability Office on how well these efforts are helping develop new treatments for kids.

Your Vote